G. Westera

2.1k total citations
83 papers, 1.5k citations indexed

About

G. Westera is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Organic Chemistry. According to data from OpenAlex, G. Westera has authored 83 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Radiology, Nuclear Medicine and Imaging, 22 papers in Molecular Biology and 13 papers in Organic Chemistry. Recurrent topics in G. Westera's work include Medical Imaging Techniques and Applications (21 papers), Radiopharmaceutical Chemistry and Applications (20 papers) and Cardiac Imaging and Diagnostics (17 papers). G. Westera is often cited by papers focused on Medical Imaging Techniques and Applications (21 papers), Radiopharmaceutical Chemistry and Applications (20 papers) and Cardiac Imaging and Diagnostics (17 papers). G. Westera collaborates with scholars based in Switzerland, Netherlands and Germany. G. Westera's co-authors include Alfred Buck, Gustav K. von Schulthess, Ernst E. van der Wall, G. A. K. Heidendal, Bruno Weber, W. den Hollander, J. P. Roos, P. August Schubiger, Hubert John and Daniel T. Schmid and has published in prestigious journals such as Circulation, NeuroImage and Radiology.

In The Last Decade

G. Westera

83 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Westera Switzerland 21 844 340 315 151 137 83 1.5k
Timothy J. Tewson United States 27 1.1k 1.4× 383 1.1× 166 0.5× 233 1.5× 63 0.5× 63 2.0k
Edward J. Delikatny United States 28 645 0.8× 764 2.2× 357 1.1× 179 1.2× 96 0.7× 100 2.1k
C. J. Koch United States 25 416 0.5× 971 2.9× 291 0.9× 277 1.8× 95 0.7× 57 2.2k
Brian M. Gallagher United States 19 814 1.0× 368 1.1× 240 0.8× 277 1.8× 49 0.4× 46 1.6k
David Y. Lewis United Kingdom 22 502 0.6× 596 1.8× 272 0.9× 188 1.2× 64 0.5× 50 1.6k
Bruce H. Mock United States 23 716 0.8× 424 1.2× 162 0.5× 249 1.6× 40 0.3× 62 1.8k
Franz Oberdorfer Germany 21 1.3k 1.5× 404 1.2× 414 1.3× 440 2.9× 93 0.7× 82 2.4k
Terry L. Sharp United States 21 997 1.2× 391 1.1× 299 0.9× 264 1.7× 23 0.2× 33 1.7k
Steen Jakobsen Denmark 24 477 0.6× 504 1.5× 174 0.6× 205 1.4× 39 0.3× 54 1.5k
Junji Konishi Japan 20 999 1.2× 218 0.6× 272 0.9× 165 1.1× 60 0.4× 44 1.7k

Countries citing papers authored by G. Westera

Since Specialization
Citations

This map shows the geographic impact of G. Westera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Westera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Westera more than expected).

Fields of papers citing papers by G. Westera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Westera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Westera. The network helps show where G. Westera may publish in the future.

Co-authorship network of co-authors of G. Westera

This figure shows the co-authorship network connecting the top 25 collaborators of G. Westera. A scholar is included among the top collaborators of G. Westera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Westera. G. Westera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Quednow, Boris B., Valérie Treyer, Felix Hasler, et al.. (2011). Assessment of serotonin release capacity in the human brain using dexfenfluramine challenge and [18F]altanserin positron emission tomography. NeuroImage. 59(4). 3922–3932. 23 indexed citations
2.
Hasler, Felix, Olga Kuznetsova, Р. Н. Красикова, et al.. (2008). GMP-compliant radiosynthesis of [18F]altanserin and human plasma metabolite studies. Applied Radiation and Isotopes. 67(4). 598–601. 8 indexed citations
3.
Bisson, William H., G. Westera, P. A. Schubiger, & Léonardo Scapozza. (2008). Homology modeling and dynamics of the extracellular domain of rat and human neuronal nicotinic acetylcholine receptor subtypes α4β2 and α7. Journal of Molecular Modeling. 14(10). 891–899. 19 indexed citations
4.
Mu, Linjing, et al.. (2006). Synthesis and binding studies of epibatidine analogues as ligands for the nicotinic acetylcholine receptors. European Journal of Medicinal Chemistry. 41(5). 640–650. 18 indexed citations
5.
Wyss, Matthias T., Jens Pahnke, Gregoire Biollaz, et al.. (2006). Uptake of 18F-fluorocholine, 18F-fluoro-ethyl-L-tyrosine and 18F-fluoro-2-deoxyglucose in F98 gliomas in the rat. European Journal of Nuclear Medicine and Molecular Imaging. 33(6). 673–682. 32 indexed citations
6.
Schmid, Daniel T., Hubert John, G. Westera, et al.. (2005). Fluorocholine PET/CT in Patients with Prostate Cancer: Initial Experience. Radiology. 235(2). 623–628. 186 indexed citations
7.
Westera, G., et al.. (2005). Qualitätskontrolle von Radiopharmaka: Beachtenswerte Besonderheiten. Pharmazie in unserer Zeit. 34(6). 506–513. 2 indexed citations
8.
Itier, Valérie, Eliane Tribollet, Michael Honer, et al.. (2004). A-186253, a specific antagonist of the α4β2 nAChRs: its properties and potential to study brain nicotinic acetylcholine receptors. Neuropharmacology. 47(4). 538–557. 6 indexed citations
9.
Westera, G. & P. August Schubiger. (2003). Functional Imaging of Physiological Processes by Positron Emission Tomography. Physiology. 18(4). 175–178. 2 indexed citations
10.
Kaim, Achim H., Bruno Weber, Michael Kurrer, et al.. (2002). 18F-FDG and 18F-FET uptake in experimental soft tissue infection. European Journal of Nuclear Medicine and Molecular Imaging. 29(5). 648–654. 101 indexed citations
11.
12.
13.
Curtis, Logos, Florence Chiodini, Sonia Bertrand, et al.. (2000). A new look at the neuronal nicotinic acetylcholine receptor pharmacophore. European Journal of Pharmacology. 393(1-3). 155–163. 19 indexed citations
14.
Patt, J. T., et al.. (1999). Synthesis and in vivo studies of [C-11]N-methylepibatidine: comparison of the stereoisomers. Nuclear Medicine and Biology. 26(2). 165–173. 21 indexed citations
15.
Bertrand, Sonia, et al.. (1999). Neuronal nAChR stereoselectivity to non‐natural epibatidine derivatives. FEBS Letters. 450(3). 273–279. 12 indexed citations
16.
Bertrand, Sonia, et al.. (1999). Synthesis and Electrophysiological Studies of a Novel Epibatidine Analogue. Journal of Receptors and Signal Transduction. 19(1-4). 521–531. 7 indexed citations
17.
Westera, G., Alfred Buck, Cyrill Burger, et al.. (1996). Carbon-11 and iodine-123 labelled iomazenil: a direct PET-SPET comparison. European Journal of Nuclear Medicine and Molecular Imaging. 23(1). 5–12. 20 indexed citations
18.
Buck, Alfred, et al.. (1995). Iodine-123-IBF SPECT evaluation of extrapyramidal diseases.. PubMed. 36(7). 1196–200. 25 indexed citations
19.
Smith, A. R., et al.. (1989). Immunolocalisation and imaging of small cell cancer xenografts by the IgG2a monoclonal antibody SWA11. British Journal of Cancer. 59(2). 174–178. 34 indexed citations
20.
Ouellet, René, Jacques Rousseau, Nicole Brasseur, et al.. (1984). Synthesis, receptor binding, and target-tissue uptake of carbon-11 labeled carbamate derivatives of estradiol and hexestrol. Journal of Medicinal Chemistry. 27(4). 509–513. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Timothy J. Tewson Breakdown of academic impact, for papers by Edward J. Delikatny Breakdown of academic impact, for papers by C. J. Koch Breakdown of academic impact, for papers by Brian M. Gallagher Breakdown of academic impact, for papers by David Y. Lewis Breakdown of academic impact, for papers by Bruce H. Mock Breakdown of academic impact, for papers by Franz Oberdorfer Breakdown of academic impact, for papers by Terry L. Sharp Breakdown of academic impact, for papers by Steen Jakobsen Breakdown of academic impact, for papers by Junji Konishi
Rankless by CCL
2026